1. Home
  2. NVAX vs ERO Comparison

NVAX vs ERO Comparison

Compare NVAX & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • ERO
  • Stock Information
  • Founded
  • NVAX 1987
  • ERO 2016
  • Country
  • NVAX United States
  • ERO Canada
  • Employees
  • NVAX N/A
  • ERO N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ERO
  • Sector
  • NVAX Health Care
  • ERO
  • Exchange
  • NVAX Nasdaq
  • ERO Nasdaq
  • Market Cap
  • NVAX 1.3B
  • ERO 1.3B
  • IPO Year
  • NVAX 1995
  • ERO N/A
  • Fundamental
  • Price
  • NVAX $6.80
  • ERO $16.91
  • Analyst Decision
  • NVAX Buy
  • ERO Strong Buy
  • Analyst Count
  • NVAX 5
  • ERO 1
  • Target Price
  • NVAX $16.60
  • ERO $19.00
  • AVG Volume (30 Days)
  • NVAX 5.2M
  • ERO 528.7K
  • Earning Date
  • NVAX 08-07-2025
  • ERO 07-31-2025
  • Dividend Yield
  • NVAX N/A
  • ERO N/A
  • EPS Growth
  • NVAX N/A
  • ERO N/A
  • EPS
  • NVAX 2.97
  • ERO 0.18
  • Revenue
  • NVAX $1,254,962,000.00
  • ERO $489,554,000.00
  • Revenue This Year
  • NVAX $56.85
  • ERO $73.94
  • Revenue Next Year
  • NVAX N/A
  • ERO $20.16
  • P/E Ratio
  • NVAX $2.29
  • ERO $91.29
  • Revenue Growth
  • NVAX 25.92
  • ERO 13.24
  • 52 Week Low
  • NVAX $5.01
  • ERO $9.30
  • 52 Week High
  • NVAX $17.81
  • ERO $23.40
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.68
  • ERO 62.73
  • Support Level
  • NVAX $6.23
  • ERO $16.53
  • Resistance Level
  • NVAX $6.90
  • ERO $18.10
  • Average True Range (ATR)
  • NVAX 0.30
  • ERO 0.66
  • MACD
  • NVAX 0.01
  • ERO 0.06
  • Stochastic Oscillator
  • NVAX 67.00
  • ERO 64.69

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

Share on Social Networks: